Call  +41 61 926 6040
Fax +41 61 926 6049
Toggle Nav
My Cart
Search
Advanced Search
Account
Settings

Proteins

Toggle Nav

Items 41-50 of 168

Page
per page
Set Descending Direction
  1. Fas (human):Fc (human) (rec.)
    AG-40B-0082
    AG-40B-0082-C05050 µg
    CHF 300.00
    AG-40B-0082-30503 x 50 µg
    CHF 600.00
    Add to Compare
    Learn More
  2. FasL (human) (multimeric) (rec.)
    AG-40B-0130
    AG-40B-0130-C01010 µg
    CHF 380.00
    AG-40B-0130-30103 x 10 µg
    CHF 760.00
    Equivalent to MegaLigands
    Add to Compare
    Learn More
    Oligomerisation of FasL (h) efficiently triggers Jurkat cell death.Method: Jurkat cells were treated O/N with the indicated concentrations of FasL (human) (multimeric) (rec.) (Prod. No. AG-40B-0130), Fc:FasL, Soluble (human) (rec.) (Prod. No.
  3. FasL, Soluble (human) (rec.)
    AG-40B-0001
    AG-40B-0001-C01010 µg
    CHF 190.00
    AG-40B-0001-30103 x 10 µg
    CHF 385.00
    Add to Compare
    Learn More
  4. Fc (human):BAFF (human) (rec.)
    AG-40B-0120
    AG-40B-0120-C01010 µg
    CHF 230.00
    AG-40B-0120-30103 x 10 µg
    CHF 460.00
    AG-40B-0120-C500500 µg
    CHF 2'400.00
    Add to Compare
    Learn More
    Restoration of the splenic T and B cell architecture in Fc-BAFF injected BAFFdeficient mice. BAFF deficient mice were injected at day 0 with 100mg BAFF (human):Fc (human) (AG-40B-0120) intravenously and at day 14 with 50mg BAFF (human):Fc (human) intraper
  5. Fc (human):Dectin-1 (mouse) (rec.)
    AG-40B-0138
    AG-40B-0138-C05050 µg
    CHF 350.00
    Add to Compare
    Learn More
  6. Fc (human):Dectin-2 (mouse) (rec.)
    AG-40B-0139
    AG-40B-0139-C05050 µg
    CHF 350.00
    Add to Compare
    Learn More
  7. Fc (human):FasL, Soluble (human) (rec.)
    AG-40B-0132
    AG-40B-0132-C01010 µg
    CHF 335.00
    AG-40B-0132-30103 x 10 µg
    CHF 670.00
    Add to Compare
    Learn More
    Oligomerisation of FasL (h) efficiently triggers Jurkat cell death.Method: Jurkat cells were treated O/N with the indicated concentrations of MegaFasL, Soluble (human) (rec.) (Prod. No. AG-40B-0130), Fc:FasL, Soluble (human) (rec.) (Pr
  8. Fc (human):FGL1 (mouse) (rec.)
    AG-40B-0185
    AG-40B-0185-C01010 µg
    CHF 240.00
    AG-40B-0185-30103 x 10 µg
    CHF 480.00
    AG-40B-0185-C100100 µg
    CHF 1'140.00
    Add to Compare
    Learn More
  9. Fc (human):FLT3 Ligand (human) (rec.)
    AG-40B-0119
    AG-40B-0119-C01010 µg
    CHF 240.00
    AG-40B-0119-30103 x 10 µg
    CHF 480.00
    AG-40B-0119-C100100 µg
    CHF 960.00
    Add to Compare
    Learn More
    Influence of FLT3L treatment on lymphocyte subpopulations. Method: C57BL/6 mice were injected intraperitoneally with 10 μg daily or were left untreated. (A) Percentages of indicated splenic subpopulations in FLT3L KO, WT control or WT-treated mice.
  10. Fc (human):FNDC4 (rec.)
    AG-40B-0213
    AG-40B-0213-C05050 µg
    CHF 330.00
    AG-40B-0213-30503 x 50 µg
    CHF 660.00
    Add to Compare
    Learn More

Items 41-50 of 168

Page
per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.